Dear Colleagues, Today we are excited to announce 16 speakers who will form part of the GAP 2020 conference program. With the final program to be announced in the New Year. Joining us from America and MD Anderson Cancer Centre: Patrick Hwu, MD Jeffrey E. Gershenwald, MD Kathleen M. Schmeler, MD...
Peter Mac scientists have found a way to target acute myeloid leukaemia (AML) at its source - a discovery that could yield a more effective treatment for this aggressive and often incurable blood cancer.
A study has confirmed the accuracy of iPrevent, an online tool developed at Peter Mac to help women understand and reduce their risk of breast cancer. The study of almost 16,000 women, published in JNCI Cancer Spectrum, found iPrevent gave accurate predictions of their breast cancer risk over a ten-year period.
Cellular immune therapies are revolutionising cancer treatment and have been especially effective at combating blood cancers; now a team at Peter Mac and Monash Biomedicine Discovery Institute (BDI), led by Professor Tony Tiganis, may have found a way to extend this therapy to the treatment of solid tumours.
Specialised immune cells, capable of killing off infections and cancers, can escape their own destructive properties through the action of a protective outer shield, researchers from Peter Mac and the University College London have discovered.
The Peter MacCallum Cancer Centre acknowledges the traditional
owners of the land on which our five sites are located throughout Victoria.
We recognise their strength and resilience and pay our respects
to their Elders past and present.